# The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease

> **NCT00214240** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 28 (actual)

## Conditions studied

- Cytomegalovirus

## Interventions

- **DRUG:** CMV Immune globulin

## Key facts

- **NCT ID:** NCT00214240
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214240, "The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00214240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*